Kun-Ling Xie

490 total citations
10 papers, 387 citations indexed

About

Kun-Ling Xie is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Kun-Ling Xie has authored 10 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Kun-Ling Xie's work include Glycosylation and Glycoproteins Research (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Microtubule and mitosis dynamics (3 papers). Kun-Ling Xie is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Microtubule and mitosis dynamics (3 papers). Kun-Ling Xie collaborates with scholars based in China. Kun-Ling Xie's co-authors include Zekuan Xu, Jie Tang, Yi Zhu, Xiaofei Zhi, Weizhi Wang, Jinqiu Tao, Hao Xu, Jingjing Zhang, Zheng Li and Xiaoyu Zhang and has published in prestigious journals such as Free Radical Biology and Medicine, Molecular Cancer and Cancer Letters.

In The Last Decade

Kun-Ling Xie

10 papers receiving 385 citations

Peers

Countries citing papers authored by Kun-Ling Xie

Since Specialization

Citations

This map shows the geographic impact of Kun-Ling Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun-Ling Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun-Ling Xie more than expected).

Fields of papers citing papers by Kun-Ling Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun-Ling Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun-Ling Xie. The network helps show where Kun-Ling Xie may publish in the future.

Co-authorship network of co-authors of Kun-Ling Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Kun-Ling Xie. A scholar is included among the top collaborators of Kun-Ling Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun-Ling Xie. Kun-Ling Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling 2017 ·Oncotarget ·Yi Zhu, Jingjing Zhang, Yunpeng Peng, Xian Liu, Kun-Ling Xie, Jie Tang, Kuirong Jiang, Wentao Gao, Lei Tian, Kai Zhang, Zekuan Xu, Yi Miao	6
2	The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer 2016 ·Journal of Experimental & Clinical Cancer Research ·Jie Tang, Yi Zhu, Kun-Ling Xie, Xiaoyu Zhang, Xiaofei Zhi, Weizhi Wang, Zheng Li, Qun Zhang, Linjun Wang, Jiwei Wang, Zekuan Xu	27
3	Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death 2016 ·Free Radical Biology and Medicine ·Zheng Li, Jiwei Wang, Weizhi Wang, Xiaofei Zhi, Qun Zhang, Bowen Li, Linjun Wang, Kun-Ling Xie, Jinqiu Tao, Jie Tang, Song Wei, Yi Zhu, Hao Xu, (unknown), Li Yang, Zekuan Xu	24
4	miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer 2015 ·Oncotarget ·Xiaoyu Zhang, Jie Tang, Xiaofei Zhi, Kun-Ling Xie, Weizhi Wang, Zheng Li, Yi Zhu, Li Yang, Hao Xu, Zekuan Xu	94
5	Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism 2014 ·Molecular Cancer ·Jingjing Zhang, Yiyi Zhu, Kun-Ling Xie, Yunpeng Peng, Jinqiu Tao, Jie Tang, Zheng Li, Zekuan Xu, Cuncai Dai, Zhuyin Qian, Kuirong Jiang, Junli Wu, Wentao Gao, Qing Du, Yi Miao	94
6	Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: New insight into the presence of the transcript variant of MUC4 2014 ·Oncology Reports ·Kun-Ling Xie, Xiaofei Zhi, Jie Tang, Yi Zhu, Jingjing Zhang, Zheng Li, Jinqiu Tao, Zekuan Xu	12
7	Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling 2014 ·Journal of Translational Medicine ·Yi Zhu, Jingjing Zhang, Kun-Ling Xie, Jie Tang, Wenbiao Liang, Rong Zhu, Yan Zhu, Bin Wang, Jinqiu Tao, Xiaofei Zhi, Zheng Li, Wentao Gao, Kuirong Jiang, Yi Miao, Zekuan Xu	8
8	CEP55 contributes to human gastric carcinoma by regulating cell proliferation 2014 ·Tumor Biology ·Jinqiu Tao, Xiaofei Zhi, Yuan Tian, Zheng Li, Yi Zhu, Weizhi Wang, Kun-Ling Xie, Jie Tang, Xiaoyu Zhang, Linjun Wang, Zekuan Xu	63
9	Transcriptional regulation of human MUC4 gene: identification of a novel inhibitory element and its nuclear binding protein 2013 ·Molecular Biology Reports ·Jingjing Zhang, Yi Zhu, Xiong‐Fei Zhang, Wenbiao Liang, Kun-Ling Xie, Jinqiu Tao, Yunpeng Peng, Zekuan Xu, Yi Miao	8
10	MUC4-induced nuclear translocation of β-catenin: A novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer 2013 ·Cancer Letters ·Xiaofei Zhi, Jinqiu Tao, Kun-Ling Xie, Yi Zhu, Zheng Li, Jie Tang, Weizhi Wang, Hao Xu, Jingjing Zhang, Zekuan Xu	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact